Changeflow GovPing Pharma & Healthcare Blood Flow Restriction Parameters and Lower Lim...
Routine Notice Added Final

Blood Flow Restriction Parameters and Lower Limb Function in Older Adults With Dynapenia

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered clinical trial NCT07534150, a two-phase study examining limb occlusion pressure (LOP) measurements and muscle electrophysiology in older adults with dynapenia. Year one collects baseline LOP data and influencing factors; year two uses high-density surface electromyography to analyze motor unit recruitment under varying BFR pressures. No regulatory obligations imposed.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH registered clinical trial NCT07534150, a prospective observational and physiological study in older adults with dynapenia. Year one collects limb occlusion pressure measurements alongside demographic and physiological characteristics including body composition, muscle mass, and functional performance. Year two employs high-density surface electromyography to analyze motor unit recruitment patterns under varying blood flow restriction pressures.

This registry entry imposes no compliance obligations. Healthcare providers and clinical investigators conducting related research may reference the study methodology for protocol design considerations. The study registration is informational and does not create regulatory requirements for the healthcare or research community.

Archived snapshot

Apr 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Blood Flow Restriction Parameters and Lower Limb Function in Older Adults With Dynapenia

N/A NCT07534150 Kind: NA Apr 16, 2026

Abstract

The objective of the first year is to collect limb occlusion pressure (LOP) measurements in older adults with varying levels of muscle health, which will serve as foundational data for subsequent investigations on blood flow restriction (BFR) combined with resistance training in individuals with dynapenia. This phase aims to examine LOP values and their potential influencing factors, including demographic and physiological characteristics such as age, height, body weight, blood pressure, waist circumference, body fat percentage, medical history of chronic diseases, and habitual physical activity. Muscle-related assessments will include skeletal muscle mass, thigh and calf circumference, handgrip strength, and lower limb muscle strength. Functional performance will be evaluated using the five-times sit-to-stand test and the SARC-F questionnaire for sarcopenia risk screening. LOP of the lower limbs will be measured using a BFR cuff system combined with a laboratory-developed blood flow detection device. The study will further investigate whether LOP values are associated with the aforementioned factors.

The objective of the second year is to utilize high-density surface electromyography (dEMG) to analyze the electrophysiological characteristics of muscle contraction in individuals with sarcopenia under varying BFR pressures and resistance intensities. This includes examining motor unit recruitment patterns and recruitment thresholds, with the goal of identifying effective a...

Conditions: Dynapenia

Interventions: Blood Flow Restriction, Conventional Resistance Training

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 16th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07534150

Who this affects

Applies to
Clinical investigators Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Physiological research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!